ATE411810T1 - Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock - Google Patents

Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock

Info

Publication number
ATE411810T1
ATE411810T1 AT06755503T AT06755503T ATE411810T1 AT E411810 T1 ATE411810 T1 AT E411810T1 AT 06755503 T AT06755503 T AT 06755503T AT 06755503 T AT06755503 T AT 06755503T AT E411810 T1 ATE411810 T1 AT E411810T1
Authority
AT
Austria
Prior art keywords
laminarine
treatment
shock
oligolaminarin
septicaemia
Prior art date
Application number
AT06755503T
Other languages
English (en)
Inventor
Jean-Claude Yvin
Nathalie Delzenne
Original Assignee
Goemar Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goemar Lab Sa filed Critical Goemar Lab Sa
Application granted granted Critical
Publication of ATE411810T1 publication Critical patent/ATE411810T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06755503T 2005-05-18 2006-05-18 Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock ATE411810T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504983A FR2885812B1 (fr) 2005-05-18 2005-05-18 Medicament a base de laminarine ou d'oligolaminarines pour le traitement de la septicemie et du choc septique

Publications (1)

Publication Number Publication Date
ATE411810T1 true ATE411810T1 (de) 2008-11-15

Family

ID=36121515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06755503T ATE411810T1 (de) 2005-05-18 2006-05-18 Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock

Country Status (8)

Country Link
US (1) US20080227748A1 (de)
EP (1) EP1888092B1 (de)
JP (1) JP5238957B2 (de)
AT (1) ATE411810T1 (de)
CA (1) CA2609080C (de)
DE (1) DE602006003337D1 (de)
FR (1) FR2885812B1 (de)
WO (1) WO2006123059A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090123637A1 (en) * 2005-05-18 2009-05-14 Laboratoires Goemar Novel Food Ingredient and Products Containing the Same
ES2333259T3 (es) * 2005-11-21 2010-02-18 Bioatlantis Limited Composiciones destinadas a mejorar la salud intestinal y el rendimiento en animales que comprenden beta-glucanos y alfa-fucanos.
JP6372890B2 (ja) * 2013-03-08 2018-08-15 学校法人東京理科大学 乳酸菌増殖促進剤、制御性ｔ細胞増加剤、乳酸菌増殖促進方法、制御性ｔ細胞を増加させる方法、制御性ｔ細胞増加効果の評価方法、および乳酸菌増殖促進効果の評価方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816213B1 (fr) * 2000-11-03 2005-04-22 Goemar Lab Sa Medicament anti-inflammatoire et cicatrisant
US6660722B2 (en) * 2001-11-30 2003-12-09 Laboratoires Goemar S.A. Therapeutical treatments

Also Published As

Publication number Publication date
EP1888092A1 (de) 2008-02-20
FR2885812A1 (fr) 2006-11-24
JP5238957B2 (ja) 2013-07-17
WO2006123059A1 (fr) 2006-11-23
US20080227748A1 (en) 2008-09-18
CA2609080A1 (fr) 2006-11-23
EP1888092B1 (de) 2008-10-22
DE602006003337D1 (de) 2008-12-04
CA2609080C (fr) 2014-11-18
FR2885812B1 (fr) 2007-07-27
JP2008545646A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
ATE440508T1 (de) Verfahren zur behandlung und/oder vorbeugung von infektionen bei kleinkindern, die über kaiserschnitt geboren werden
DE602005012276D1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
HK1096392A1 (en) Substituted heterocycles
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
UA92593C2 (ru) Лечение мастита энрофлоксацином
UY28313A1 (es) Nonadepsipeptidos acilados
ATE433459T1 (de) Desoxo-nonadepsipeptide
UY29189A1 (es) Nonadepsipeptidos acilados ii
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
ATE455789T1 (de) Substituierte nonadepsipeptide
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
ATE411810T1 (de) Medikament aus laminarin oder oligolaminarinen zur behandlung von septikämie und schock
ATE524488T1 (de) Lysobactinamide
WO2006123164A3 (en) Lps-binding and bactericidal cytokines and interferons
ATE371461T1 (de) Verwendung von extrakten aus wurzeln von pelargonium sidoides und/oder pelargonium reniforme
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
DE60331654D1 (de) Nicht-radioaktives Strontiummittel zur Behandlung von Krebs
ATE506946T1 (de) Verbindung zur prävention und behandlung von linksventrikulärer hypertrophie bei dialyse- patienten
DE602004012759D1 (de) Behandlung von fibrosen
UA110918C2 (uk) Інгібітори протеїнфосфатази-1 та їх застосування
ATA10872004A (de) Pharmazeutische zubereitung zur behandlung von schock
SG148118A1 (en) An oral product, the preparing method and the use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties